Journal article icon

Journal article

Comparison of "Continuous" and "End-ischemic" Approaches of Oxygenated Hypothermic Machine Perfusion for Pancreas Preservation

Abstract:
BackgroundPancreas transplantation can successfully restore physiological insulin production, but it comes with a potentially significant morbidity burden. Pancreas grafts are extremely vulnerable to ischemia/reperfusion injury. Investigating technologies that aim to mitigate ischemia/reperfusion injury, such as oxygenated hypothermic machine perfusion (HMPO2) for pancreas preservation and their modes of application, is crucial to inform clinical translation.MethodsA circulatory death porcine model was used to compare different HMPO2 modes for pancreas preservation. Eighteen porcine pancreases were allocated to 3 experimental groups: static cold storage (SCS), continuous HMPO2, and end-ischemic HMPO2. Normothermic reperfusion (NR) was used for assessment.ResultsThe ischemic times and wet:dry ratios were comparable among the 3 groups. Perfusate flow increased throughout NR and was highest at the end of NR across all groups, with no significant difference between the groups. Amylase, lipase, lactate dehydrogenase, and cell-free DNA showed no significant differences in the pattern of change among the groups. Red blood cells were present consistently in vessels and islet capillaries at the end of NR in all pancreases. The continuous HMPO2 group showed significantly higher biphasic insulin secretion in response to glucose stimulation (P = 0.01).ConclusionsContinuous HMPO2 is a superior method for preserving beta-cell function compared with SCS and end-ischemic HMPO2 in a porcine model of circulatory death when assessed by NR with whole blood as a surrogate for transplantation. As end-ischemic HMPO2 is also feasible and potentially superior to SCS, testing its safety would be an excellent first step in translating this technology into clinical practice.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1097/txd.0000000000001888

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Surgical Sciences
Sub department:
Surgical Sciences
Role:
Author
ORCID:
0000-0001-5300-912X
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Surgical Sciences
Sub department:
Surgical Sciences
Role:
Author
ORCID:
0000-0002-8644-9380
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-1244-7857
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Surgical Sciences
Sub department:
Surgical Sciences
Role:
Author
ORCID:
0000-0003-3846-0101
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-3894-4600


More from this funder
Funder identifier:
https://ror.org/050rgn017


Publisher:
Lippincott, Williams & Wilkins
Journal:
Transplantation Direct More from this journal
Volume:
12
Issue:
2
Pages:
e1888
Publication date:
2026-01-15
Acceptance date:
2025-09-13
DOI:
EISSN:
2373-8731
ISSN:
2373-8731
Pmid:
41550296


Language:
English
Keywords:
Pubs id:
2361059
UUID:
uuid_ab7b3d89-4f71-43ea-b6d2-3381159c985f
Local pid:
pubs:2361059
Source identifiers:
3696210
Deposit date:
2026-01-27
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP